JSPN

Living reference work entry

Abstract

The Japanese Society for Pediatric Nephrology (JSPN; http://www.jspn.jp/en/) was founded in 1967 as a nonprofit organization to enhance and assist the study and practice of pediatric nephrology. The specific goals of the JSPN are:

Keywords

Nephrotic Syndrome Continue Professional Development Multicenter Clinical Trial Pediatric Nephrology Idiopathic Nephrotic Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Japanese Society of Nephrology. Evidence-based clinical practice guideline for CKD 2013. Clin Exp Nephrol. 2014;18:346–423. PMID: 24811483.CrossRefGoogle Scholar
  2. 2.
    Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629–37. doi:10.1681/ASN.2008030287. Epub 2009 Jan 21. PMID: 19158356.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Uemura O, Honda M, Matsuyama T, Ishikura K, Hataya H, Nagai T, Ikezumi Y, Fujita N, Ito S, Iijima K, Japanese Society for Pediatric Nephrology, the Committee of Measures for Pediatric CKD. Is the new Schwartz equation derived from serum creatinine and body length suitable for evaluation of renal function in Japanese children? Eur J Pediatr. 2012;171(9):1401–4. Epub 2012 Jun 20. PMID: 22714551.PubMedCrossRefGoogle Scholar
  4. 4.
    Uemura O, Honda M, Matsuyama T, Ishikura K, Hataya H, Yata N, Nagai T, Ikezumi Y, Fujita N, Ito S, Iijima K, Kitagawa T. Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol. 2011;15:694–9. doi:10.1007/s10157-011-0452-y. Epub 2011 Apr 21. PMID: 21505953.PubMedCrossRefGoogle Scholar
  5. 5.
    Uemura O, Nagai T, Ishikura K, Ito S, Hataya H, Gotoh Y, Fujita N, Akioka Y, Kaneko T, Honda M. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626-33. doi: 10.1007/s10157-013-0856-y. Epub 2013 Sep 7. PMID: 24013764.Google Scholar
  6. 6.
    Nagai T, Uemura O, Ishikura K, Ito S, Hataya H, Gotoh Y, Fujita N, Akioka Y, Kaneko T, Honda M. Creatinine-based equations to estimate glomerular filtration rate in Japanese children aged between 2 and 11 years old with chronic kidney disease. Clin Exp Nephrol. 2013;17:877–81. doi:10.1007/s10157-013-0799-3. Epub 2013 Apr 6. PMID: 23564380.PubMedCrossRefGoogle Scholar
  7. 7.
    Yata N, Uemura O, Honda M, Matsuyama T, Ishikura K, Hataya H, Nagai T, Ikezumi Y, Fujita N, Ito S, Iijima K, Saito M, Keneko T, Kitagawa T. Reference ranges for serum cystatin C measurements in Japanese children by using 4 automated assays. Clin Exp Nephrol. 2013;17:872–6. doi:10.1007/s10157-013-0784-x. Epub 2013 Feb 28. PMID: 23446519.PubMedCrossRefGoogle Scholar
  8. 8.
    Uemura O, Nagai T, Ishikura K, Ito S, Hataya H, Gotoh Y, Fujita N, Akioka Y, Kaneko T, Honda M. Cystatin C-based equation for estimating glomerular filtration rate in Japanese children and adolescents. Clin Exp Nephrol. 2013. [Epub ahead of print] PMID: 24253614.Google Scholar
  9. 9.
    Ikezumi Y, Honda M, Matsuyama T, Ishikura K, Hataya H, Yata N, Nagai T, Fujita N, Ito S, Iijima K, Kaneko T, Uemura O. Establishment of a normal reference value for serum β2 microglobulin in Japanese children: reevaluation of its clinical usefulness. Clin Exp Nephrol. 2013;17:99–105. doi:10.1007/s10157-012-0658-7. Epub 2012 Jul 14. PMID: 22797889.PubMedCrossRefGoogle Scholar
  10. 10.
    Ishikura K, Uemura O, Ito S, Wada N, Hattori M, Ohashi Y, Hamasaki Y, Tanaka R, Nakanishi K, Kaneko T, Honda M, Pediatric CKD Study Group, Japan Committee of Measures for Pediatric CKD of the Japanese Society of Pediatric Nephrology. Pre-dialysis chronic kidney disease in children: results of a nationwide survey in Japan. Nephrol Dial Transplant. 2013;28:2345–55. doi:10.1093/ndt/gfs611. Epub 2013 Jul 3. PMID: 23825101.PubMedCrossRefGoogle Scholar
  11. 11.
    Ishikura K, Uemura O, Hamasaki Y, Ito S, Wada N, Hattori M, Ohashi Y, Tanaka R, Nakanishi K, Kaneko T, Honda M, Pediatric CKD Study Group in Japan; Committee of Measures for Pediatric CKD of Japanese Society of Pediatric Nephrology. Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort study. Nephrol Dial Transplant. 2014;29:878–84. doi:10.1093/ndt/gfu012. Epub 2014 Feb 9. PMID: 24516225.PubMedCrossRefGoogle Scholar
  12. 12.
    Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol. 1999;10:101–9. PMID: 9890315.PubMedGoogle Scholar
  13. 13.
    Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group. Long-term results of a randomized controlled trial in childhood IgA nephropathy. Clin J Am Soc Nephrol. 2011;6:1301–7. doi:10.2215/CJN.08630910. Epub 2011 Apr 14. PMID: 21493743.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol. 2006;1:511–7. Epub 2006 Apr 5. PMID: 17699253.PubMedCrossRefGoogle Scholar
  15. 15.
    Yoshikawa N, Nakanishi K, Ishikura K, Hataya H, Iijima K, Honda M, Japanese Pediatric IgA Nephropathy Treatment Study Group. Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study. Pediatr Nephrol. 2008;23:757–63. doi:10.1007/s00467-007-0731-8. Epub 2008 Jan 26. PMID: 18224343.PubMedCrossRefGoogle Scholar
  16. 16.
    Nakanishi K, Iijima K, Ishikura K, Hataya H, Awazu M, Sako M, Honda M, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group. Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study. Pediatr Nephrol. 2009;24:845–9. doi:10.1007/s00467-008-1006-8. Epub 2008 Sep 30. PMID: 18825420.PubMedCrossRefGoogle Scholar
  17. 17.
    Ishikura K, Ikeda M, Hattori S, Yoshikawa N, Sasaki S, Iijima K, Nakanishi K, Yata N, Honda M. Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial. Kidney Int. 2008;73:1167–73. PMID: 18305467.PubMedCrossRefGoogle Scholar
  18. 18.
    Ishikura K, Yoshikawa N, Nakazato H, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ito S, Yata N, Ando T, Honda M, Japanese Study Group of Renal Disease in Children. Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children. Clin J Am Soc Nephrol. 2012;7:1576–83. PMID: 22837276.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Ishikura K, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Yata N, Ando T, Honda M, For Japanese Study Group of Renal Disease in Children. Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome. Nephrol Dial Transplant. 2010;25:3956–62. PMID: 20530497.PubMedCrossRefGoogle Scholar
  20. 20.
    Hamasaki Y, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Yata N, Kaneko T, Honda K, Japanese Study Group of Renal Disease. Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2009;24:2177–85. PMID: 19714370.PubMedCrossRefGoogle Scholar
  21. 21.
    Hamasaki Y, Yoshikawa N, Nakazato H, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Ito S, Kaneko T, Honda M, for Japanese Study Group of Renal Disease in Children. Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis. Pediatr Nephrol. 2013;28:765–71. PMID: 23314441.PubMedCrossRefGoogle Scholar
  22. 22.
    Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, Tanizawa T, Wada H, Maki S. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int. 2000;58:317–24. PMID: 10886577.PubMedCrossRefGoogle Scholar
  23. 23.
    Iijima K, Sako M, Oba MS, Ito S, Hataya H, Tanaka R, Ohwada Y, Kamei K, Shikura K, Yata N, Nozu K, Honda M, Nakamura H, Nagata M, Ohashi Y, Nakanishi K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children. Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial. Clin J Am Soc Nephrol. 2014;9:271–8. PMID: 24262503.PubMedCrossRefGoogle Scholar
  24. 24.
    Yoshikawa N, Nakanishi K, Sako M, Oba SM, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K, for the Japanese Study Group of Kidney Disease in Children. A multicenter randomized trial comparing two-month to six-month initial prednisolone treatment in childhood nephrotic syndrome. Kidney Int. 2014 Jul 23. doi: 10.1038/ki.2014.260. [Epub ahead of print] PMID: 25054775.Google Scholar
  25. 25.
    Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, On behalf of Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Rituximab for the treatment of childhood-onset complicated frequently relapsing nephrotic syndrome/steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2014;384:1273-81. doi: 10.1016/S0140-6736(14)60541-9. Epub 2014 Jun 22. PMID: 24965823.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of PediatricsKobe University Graduate School of MedicineKobeJapan

Personalised recommendations